Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 22
- Interviews
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
- Clinical Research
Is Cannabis Effective for ADHD?
Few conditions in the field of medical cannabis are backed by such adamant patient conviction, but as little clinical data as Attention Deficit Hyperactivity Disorder (ADHD).
- Events
Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge
More than 70 international speakers and over 1000 delegates set to convene on London next month for policy debates, high-level networking and the 2026 Business of Cannabis Awards Cannabis Europa, the leading B2B conference for the European cannabis industry, today announced the full programme for its 2026 London edition.
- Industry Trends
Is Spain Set to Become the Next European Cannabis Processing Hub?
As the European medical cannabis market has developed, expanded and matured over the last half-decade, Portugal has played a critical role in the global supply chain, earning a reputation as the ‘doorway to Europe’.
- Industry Trends
Germany Now Represents 62% of Canadian Cannabis Flower Exports as Portugal’s Share Collapses
Canadian cannabis exports totalled CA$51.6 million in February 2026 across the three main cannabis HS codes tracked in export data, up 8.7% on the same month a year earlier.
- Business
How to Start a Cannabis Business: A Complete Guide
The global legal cannabis industry is no longer an emerging market, but a maturing one with established regulatory frameworks, institutional capital, and a growing ecosystem of professional services.
- Medical Cannabis
The Right Reforms, the Wrong Narrative: Why the Medical Cannabis Debate Is Missing Half the Picture
Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the BBC, The i Paper, Private Eye, and a swathe of other national and local publications.
- Public Markets
Green Shoots: Spring 2026 Brings Integration, Recovery, and New Supply Chains to Global Cannabis
The second quarter of 2026 has brought tentative signs of stabilisation to a cannabis sector that spent much of 2025 fighting for survival.
- Medical Cannabis
Five Years, 74 Patients: Ireland Moves Forward With Review of Its Failing Medical Cannabis Programme
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis Access Programme (MCAP) following months of parliamentary pressure.
- CBD Market
CBD Enters US Healthcare Through Medicare Pilot, But Coverage Remains Limited
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost cannabis stocks.
- Opinion
Is the ‘Commercial Scale’ of Medical Cannabis in the UK Inappropriate?
As the UK’s medical cannabis industry continues to come under fierce scrutiny from the country’s mainstream media, James Duckenfield, CEO of UK-based cannabis cultivator Glass Pharms, argues that the focus should be on ensuring compliance with the existing regulatory framework rather than sensationalising a prescribing rate that remains a small fraction of demonstrable clinical need.
- UK & Europe
Züri Can Extended By Two Years As Results Point To Black Market Deterrence
Zurich’s municipal parliament has voted to extend its flagship adult-use cannabis pilot, Züri Can, by a further two years to October 2028, and to provide an additional CHF 800,000 in funding, in a 101-13 vote that laid bare the fault lines in Swiss cannabis politics.
